Zehtab S, Sattarzadeh Bardsiri M, Mirzaee Khalilabadi R, Ehsan M, Fatemi A (2022) Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis. BMC Res Notes 15:46

Article  PubMed  PubMed Central  CAS  Google Scholar 

Abo-Bakr A, Mossallam G, El Azhary N, Hafez H, Badawy R (2017) Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia. J Egypt Natl Canc Inst 29:127–133

Article  PubMed  Google Scholar 

Mrózek K, Heerema NA, Bloomfield CD (2004) Cytogenetics in acute leukemia. Blood Rev 18:115–136

Article  PubMed  Google Scholar 

Yamamoto FI, Clausen H, White T, Marken J, Hakomori SI (1990) Molecular genetic basis of the histo-blood group ABO system. Nature 345:229–233

Article  PubMed  CAS  Google Scholar 

Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 5:14

Article  PubMed  PubMed Central  Google Scholar 

Eikenboom J, Federici AB, Dirven RJ, Castaman G, Rodeghiero F, Budde U et al (2013) VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease. Blood 121:2336–2339

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yu H, Xu N, Li ZK, Xia H, Ren HT, Li N et al (2020) Association of ABO blood groups and risk of gastric cancer. Scand J Surg 109:309–313

Article  PubMed  Google Scholar 

Li Y, Liu L, Huang Y, Zheng H, Li L (2020) Association of ABO polymorphisms and pancreatic cancer/cardiocerebrovascular disease: a meta-analysis. BMC Med Genet 21:41

Article  PubMed  PubMed Central  Google Scholar 

Zhang BL, He N, Huang YB, Song FJ, Chen KX (2014) ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev 15:4643–4650

Article  PubMed  Google Scholar 

Miao S, Zhou W, Chen L, Wang S, Liu X (2014) Influence of ABO blood group and R hesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244 768 controls. Asia-Pac J Clncl Oncol 10:101–108

Article  Google Scholar 

Fukumoto K, Taniguchi T, Usami N, Kawaguchi K, Fukui T, Ishiguro F et al (2015) The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer. J Epidemiol 25:110–116

Article  PubMed  Google Scholar 

Li Q, Wu T, Ma XA, Jing L, Han LL, Guo H (2018) Prognostic role of ABO blood group in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. TCRM 14:991–998

Article  CAS  Google Scholar 

Joh HK, Cho E, Choueiri TK (2012) ABO blood group and risk of renal cell cancer. Cancer Epidemiol 36:528–532

Article  PubMed  PubMed Central  CAS  Google Scholar 

Göçer M, Kurtoğlu E (2021) Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma. Memo 14:235–240

Article  PubMed  Google Scholar 

Stakišaitis D, Juknevičienė M, Ulys A, Žaliūnienė D, Stanislovaitienė D, Šepetienė R et al (2018) ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. Oncol Lett. https://doi.org/10.3892/ol.2018.8749

Article  PubMed  PubMed Central  Google Scholar 

Osada Y, Ito C, Nishiyama-Fujita Y, Ogura S, Sakurai A, Akimoto M et al (2020) Prognostic impact of ABO blood group on survival in patients with malignant lymphoma. Clin Lymphoma Myeloma Leuk 20:122–129

Article  PubMed  Google Scholar 

Chen Y, Hu N, Liao L, Yu K, Shu XO, Zheng W et al (2021) ABO genotypes and the risk of esophageal and gastric cancers. BMC Cancer 21:589

Article  PubMed  PubMed Central  CAS  Google Scholar 

Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB et al (2010) Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 19:1863–1872

Article  PubMed  PubMed Central  CAS  Google Scholar 

Murray GP, Post SR, Post GR (2020) ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. J Clin Pathol 73:347–349

Article  PubMed  CAS  Google Scholar 

Franchini M, Frattini F, Crestani S, Bonfanti C, Lippi G (2013) von Willebrand factor and cancer: a renewed interest. Thromb Res 131:290–292

Article  PubMed  CAS  Google Scholar 

Schellerer VS, Mueller-Bergh L, Merkel S, Zimmermann R, Weiss D, Schlabrakowski A et al (2011) The clinical value of von Willebrand factor in colorectal carcinomas. Am J Transl Res 3:445–453

PubMed  PubMed Central  CAS  Google Scholar 

Ablin RJ, Bartkus JM, Gonder MJ (1988) Immunoquantitation of factor VIII-related antigen (Von Willebrand factor antigen) in prostate cancer. Cancer Lett 40:283–289

Article  PubMed  CAS  Google Scholar 

Goh CY, Patmore S, Smolenski A, Howard J, Evans S, O’Sullivan J et al (2021) The role of von Willebrand factor in breast cancer metastasis. Transl Oncol 14:101033

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gadducci A, Baicchi U, Marrai R, Facchini V, Del Bravo B, Fosella PV et al (1993) Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand Factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 49:354–358

Article  PubMed  CAS  Google Scholar 

Yang AJ, Wang M, Wang Y, Cai W, Li Q, Zhao TT et al (2018) Cancer cell-derived von Willebrand factor enhanced metastasis of gastric adenocarcinoma. Oncogenesis 7:12

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Wang X, Li S, Hu H, Zhang D, Hu P et al (2014) The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study. J Proteomics 106:99–112

Article  PubMed  CAS  Google Scholar 

Hussein R, Saleh J (2017) Relationship plasma levels of Von Willbrand factor with peripheral blasts and chemotherapy in Syrian children with acute lymphoblastic leukemia 10

Mojiri A, Stoletov K, Lorenzana Carrillo MA, Willetts L, Jain S, Godbout R et al (2017) Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget 8:13015–13029

Article  PubMed  Google Scholar 

Franchini M, Lippi G (2015) The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. BMC Med 13:7

Article  PubMed  PubMed Central  Google Scholar 

Patmore S, Dhami SPS, O’Sullivan JM (2020) Von Willebrand factor and cancer; metastasis and coagulopathies. J Thromb Haemost 18:2444–2456

Article  PubMed  Google Scholar 

Colonne CK, Favaloro EJ, Pasalic L (2022) The intriguing connections between von Willebrand factor, ADAMTS13 and cancer. Healthcare 10:557

Article  PubMed  PubMed Central  Google Scholar 

Goumidi L, Thibord F, Wiggins KL, Li-Gao R, Brown MR, van Hylckama VA et al (2021) Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood 137:2394–2402

Article  PubMed  PubMed Central  CAS